This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Genzyme Corporation. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Innovations by Kristina An Haack
Introduction
Kristina An Haack is a prominent inventor based in Shanghai, China. She has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment of Pompe disease. With a total of 2 patents, her work is paving the way for advancements in medical treatments.
Latest Patents
Kristina's latest patents include innovative methods for treating late-onset Pompe disease. The first patent provides methods of treating late-onset Pompe disease (LOPD) using a pharmaceutical composition comprising an oligosaccharide-acid α-glucosidase (GAA) conjugate, such as avalglucosidase alfa. The second patent focuses on treating infantile-onset Pompe disease (IOPD) with similar pharmaceutical compositions and formulations of the oligosaccharide-GAA conjugates.
Career Highlights
Kristina An Haack is currently associated with Genzyme Corporation, where she continues to develop groundbreaking treatments. Her expertise in pharmaceutical sciences has positioned her as a key figure in her field.
Collaborations
Some of her notable coworkers include Catherine Wilson and Patrick Finn, who contribute to her innovative projects and research endeavors.
Conclusion
Kristina An Haack's work exemplifies the impact of innovation in the medical field, particularly in the treatment of Pompe disease. Her contributions are vital for advancing healthcare solutions and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile